The factors predicting pneumonia in COVID-19 patients: preliminary results from a university hospital in Turkey

Background/aim: Pneumonia is the most serious clinical presentation of COVID-19. This study aimed to determine the demographic, clinical, and laboratory findings that can properly predict COVID-19 pneumonia. Materials and methods: This study was conducted in the Gazi University hospital. All hospitalized patients with confirmed and suspected SARS-CoV-2 infection between 16 March 2020 and 30 April 2020 were analyzed retrospectively. COVID-19 patients were separated into two groups, pneumonia and nonpneumonia, and then compared to determine predicting factors for COVID-19 pneumonia. Variables that had a P-value of less than 0.20 and were not correlated with each other were included in the logistic regression model. Results: Of the 247 patients included in the study 58% were female, and the median age was 40. COVID-19 was confirmed in 70.9% of these patients. Among the confirmed COVID-19 cases, 21.4% had pneumonia. In the multivariate analysis male sex (P = 0.028), hypertension (P = 0.022), and shortness of breath on hospital admission (P = 0.025) were significant factors predicting COVID-19 pneumonia. Conclusion: Shortness of breath, male sex, and hypertension were significant for predicting COVID-19 pneumonia on admission. Patients with these factors should be evaluated more carefully for diagnostic procedures, such as thorax CT.

PDF

___

1. World Health Organization (2020). Coronavirus disease (COVID-19) situation report – 126 [online]. Website https:// www.who.int/emergencies/diseases/novel-coronavirus-2019/ situation-reports [accessed 15 May 2020].
2. Wu C, Chen X, Cai Y, Xia J, Zhou X et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. Journal of Medical Association Internal Medicine 2020; e200994. [Online ahead of print] doi: 10.1001/jamainternmed.2020.0994
3. T.C. Sağlık Bakanlığı (2020). Tükiye günlük koronavirüs tablosu [online]. Website https://covid19.saglik.gov.tr/ [accessed 28 May 2020].
4. Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: a review. Clinical Immunology 2020; 215: 108427. doi: 10.1016/j.clim.2020.108427
5. World Health Organisation (2020). Clinical management of COVID-19 interim guidance [online]. Website https://www. who.int/publications/i/item/clinical-management-of-covid-19 [accessed 28 May 2020].
6. T.C. Sağlık Bakanlığı (2020). COVID-19 (SARS-CoV-2 enfeksiyonu) rehberi. Website https://covid19bilgi.saglik.gov. tr/tr/covid-19-rehberi.html [accessed 14 May 2020].
7. Simpson S, Kay FU, Abbara S, Bhalla S, Chung JH et al. Radiological society of North America expert consensus statement on reporting chest ct findings related to COVID-19. Endorsed by the society of thoracic radiology, the American college of radiology, and RSNA. Journal of Thoracic Imaging 2020. [Online ahead of print] doi: 10.1097/ RTI.0000000000000524
8. Myers LC, Parodi SM, Escobar GJ, Liu VX. Characteristics of hospitalized adults with COVID-19 in an integrated health care system in California. Journal of the American Medical Association 2020; 323 (21): 2195-2198. doi: 10.1001/ jama.2020.7202
9. Xie J, Tong Z, Guan X, Du B, Qiu H. clinical characteristics of patients who died of coronavirus disease 2019 in China. Journal of the American Medical Association Network Open 2020; 3 (4): e205619. doi: 10.1001/jamanetworkopen.2020.5619
10. Zheng Z, Peng F, Xu B, Zhao J, Liu H et al. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. The Journal of Infection 2020. [Online ahead of print] doi: 10.1016/j.jinf.2020.04.021
11. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. Journal of the American Medical Association 2020; 323 (20): 2052-2059. doi: 10.1001/jama.2020.6775
12. Fu L, Wang B, Yuan T, Chen X, Ao Y et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis. Journal of Infection 2020; 80 (6): 656-665. doi: 10.1016/j.jinf.2020.03.041
13. Yang J, Zheng Y, Gou X, Pu K, Chen Z et al. Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: a systematic review and meta-analysis. International Journal of Infectious Diseases 2020; 94: 91-95. doi: 10.1016/j. ijid.2020.03.017
14. Cao Y, Liu X, Xiong L, Cai K. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis. Journal of Medical Virology 2020; 1-11. [Online ahead of print] doi: 10.1002/ jmv.25822
15. Zhao Q, Meng M, Kumar R, Wu Y, Huang J et al. The impact of COPD and smoking history on the severity of Covid-19: a systemic review and meta-analysis. Journal of Medical Virology 2020; 1-7. [Online ahead of print] doi: 10.1002/jmv.25889
16. Zuin M, Rigatelli G, Zuliani G, Rigatelli A, Mazza A et al.. Arterial hypertension and risk of death in patients with COVID-19 infection: systematic review and meta-analysis. Journal of Infection 2020; 81 (1): e84-86. doi: 10.1016/j. jinf.2020.03.059.
17. Guo J, Huang Z, Lin L, Lv J. Coronavirus disease 2019 (COVID-19) and cardiovascular disease: a viewpoint on the potential influence of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome coronavirus 2 infection. Journal of the American Heart Association 2020; 9 (7): e016219. doi: 10.1161/JAHA.120.016219
18. Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM et al. COVID-19 and cardiovascular disease. Circulation 2020; 141 (20): 1648-1655. doi: 10.1161/ CIRCULATIONAHA.120.046941
19. Cevik M, Bamford C, Ho A. COVID-19 pandemic - a focused review for clinicians. Clinical Microbiology and Infection 2020. [Online ahead of print] doi: 10.1016/j.cmi.2020.04.023
20. Li LQ, Huang T, Wang YQ, Wang ZP, Liang Y et al. COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta-analysis. Journal of Medical Virology 2020. [Online ahead of print] doi: 10.1002/jmv.25757
21. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ et al. Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine 2020; 382 (18): 1708-1720. doi: 10.1056/NEJMoa2002032
22. Tian S, Hu N, Lou J, Chen K, Kang X et al. Characteristics of COVID-19 infection in Beijing. Journal of Infection 2020; 80 (4): 401-406. doi: 10.1056/NEJMoa2002032
23. Kim GU, Kim MJ, Ra SH, Lee J, Bae S et al. Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19. Clinical Microbiology and Infection 2020. [Online ahead of print] doi: 10.1016/j.cmi.2020.04.040
24. Zhou F, Yu T, Du R, Fan G, Liu Y et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395 (10229): 1054-1062. doi: 10.1016/S0140-6736(20)30566-3
25. Wang D, Hu B, Hu C, Zhu F, Liu X et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirusinfected pneumonia in Wuhan, China. Journal of American Medical Association 2020; 323 (11): 1061-1069. doi: 10.1001/ jama.2020.1585
26. Zhao Q, Meng M, Kumar R, Wu Y, Huang J et al. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a systemic review and meta-analysis. International Journal of Infectious Diseses 2020; 96: 131-135. doi: 10.1016/j. ijid.2020.04.086